By Mill Chart
Last update: May 9, 2024
Growth investors are on the lookout for stocks displaying robust revenue and EPS growth. In this analysis, we'll assess whether CORCEPT THERAPEUTICS INC (NASDAQ:CORT) aligns with growth investing criteria, especially as it consolidates and signals a possible breakout. As always, investors should conduct their own research, but CORCEPT THERAPEUTICS INC has surfaced on our radar for growth with base formation, warranting further examination.
ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NASDAQ:CORT has earned a 8 for growth:
Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:CORT has achieved a 9 out of 10:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:CORT was assigned a score of 8 for profitability:
Besides the Technical Rating, ChartMill also assign a Setup Rating to every stock. This setup score also ranges from 0 to 10 and determines to which extend the stock is consolidating. This is achieved by evaluating multiple short term technical indicators. NASDAQ:CORT currently has a 7 as setup rating:
Although the technical rating is only medium, CORT does present a nice setup opportunity. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 25.41. Right above this resistance zone may be a good entry point. We notice that large players showed an interest for CORT in the last couple of days, which is a good sign.
More Strong Growth stocks can be found in our Strong Growth screener.
For an up to date full fundamental analysis you can check the fundamental report of CORT
Check the latest full technical report of CORT for a complete technical analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
73.53
+0.93 (+1.28%)
Find more stocks in the Stock Screener
CORCEPT THERAPEUTICS INC could be undervalued. NASDAQ:CORT is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced.